Pharmacokinetics of DA‐8159, a New Erectogenic, after Intravenous and Oral Administration to Rats: Hepatic and Intestinal First‐Pass Effects

This publication has 20 references indexed in Scilit:

• Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect
  Journal of Pharmaceutical Sciences, 2003
• Dose-Independent Pharmacokinetics of a New Neuroprotective Agent for Ischemia-Reperfusion Damage, KR-31543, after Intravenous and Oral Administration to Rats: Hepatic and Intestinal First-Pass Effects
  Journal of Pharmaceutical Sciences, 2003
• Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats
  Life Sciences, 2002
• Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA‐8159, using an equilibrium dialysis technique
  Biopharmaceutics & Drug Disposition, 2000
• Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutrition
  Journal of Pharmacokinetics and Biopharmaceutics, 1993
• Kinetics of Aluminum in Rats. Ill: Effect of Route of Administration
  Journal of Pharmaceutical Sciences, 1992
• Evaluation of potential causes for the incomplete bioavailability of furosemide: Gastric first-pass metabolism
  Journal of Pharmacokinetics and Biopharmaceutics, 1983
• New Calculation method of mean Total Body Clearance of Drugs and its Application to Dosage Regimens
  Journal of Pharmaceutical Sciences, 1980
• Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curve
  Journal of Pharmacokinetics and Biopharmaceutics, 1978
• Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects
  Journal of Pharmacokinetics and Biopharmaceutics, 1977